Ultragenyx CEO talks the company's path to profitability in developing drugs for rare diseases

(3:38)

Ultragenyx Pharmaceutical

(14:54)

I'm Rare at Ultragenyx

(2:49)

Ultragenyx is building a gene therapy plant

(2:12)

Ultragenyx Pharmaceutical - Dr Zoe Farrington - Gene Therapy

(16:44)

Ultragenyx: Built to be Rare

(2:48)

Ultragenyx Pharmaceutical Inc.: Overcoming Challenges

(23:47)

What a Pharmaceutical Executive has Learned Working with Rare Disease Patients

(1:1econd)

Kimberly Goodspeed (Ultragenyx Pharmaceuticals) | 2024 FAST Global Summit on Angelman Syndrome

(39:33)

Working at Ultragenyx Pharmaceutical - May 2018

(46)

Ultragenyx Pharmaceutical Community Update

(7:56)

2023 Ultragenyx Update

(10:59)

Ultragenyx

(15:45)

Gene Therapy: What Does It Mean for Rare Disease Communities?

(28:8)

Rare Bootcamp: Empowering Rare Disease Warriors for the Battle

(1:55)

Ultragenyx Pharmaceutical RARE Q3 2024 Earnings Presentation

(1:3:50)

Ultragenyx Pharmaceutical RARE Q1 2024 Earnings Presentation

(59:26)

Ultraimpact

(3:46)

What you need to know about the Ultragenyx gene therapy trial for Wilson disease

(14:56)

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

(3:11)

BLUE Stock (bluebird bio stock analysis) BLUE STOCK PREDICTIONS BLUE STOCK Analysis BLUE STOCK NEWS

(1:3)

Overview of Illumina Sequencing by Synthesis Workflow

(5:13)

Ultragenyx Ventures into Gene Therapy for Wilson Disease

(6:32)